• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, January 31, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Highlights from the journal CHEST®, January 2023

Bioengineer by Bioengineer
January 18, 2023
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

Do Inhaled Corticosteroids Reduce All-Cause Mortality Risk in Patients With COPD?

Credit: Hong Chen, MD, et al. CHEST January 2023

Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The January issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Starting in late 2022, readers have been earning continuing medical education (CME) credit for reading select journal CHEST articles and completing a posttest through the CHEST education portal,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “The articles eligible for CME in January are, ‘Association of Inhaled Corticosteroids With All-Cause Mortality Risk inPatients With COPD,’ which is highlighted below, and ‘Long-term Azithromycin in Children With Bronchiectasis Unrelated toCystic Fibrosis.’”

Also included in the current issue of the journal CHEST:

  • COPD
    A meta-analysis of 60 randomized clinical trials, “Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD,” demonstrated a reduced all-cause mortality risk in patients treated with inhaled corticosteroids as part of their therapy regimen. A visual abstract for the research can be viewed here.
  • Critical Care
    “Temporal Trends and Variation in Bronchoscopy Use for Acute RespiratoryFailure in the United States” finds that the variable use of bronchoscopy among mechanically ventilated patients with respiratory failure suggests potentially unwarranted practice variation and need for further studies to clarify which patients may benefit from bronchoscopy. A visual abstract for the research can be viewed here.
  • Thoracic Oncology
    A research letter, “A Biomarker-Based Approach for the Determination of Sample Adequacy During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration,” finds that a multivariate biomarker approach accurately reflects endobronchial ultrasound-guided transbronchial needle aspiration samples arising from predominantly lymphoid tissue and is suitable for subsequent diagnostic testing. A podcast of experts discussing the research can be found here.
  • Pulmonary Vascular
    Original research, “Sex Differences in Outcomes of Percutaneous Pulmonary ArteryThrombectomy in Patients With Pulmonary Embolism,” finds that women had higher rates of in-hospital mortality, procedural bleeding, increased quantities of blood product transfusions and increased vascular complications. An editorial related to the research can be found here.

To view the entire January issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.



Journal

the journal CHEST

Share12Tweet8Share2ShareShareShare2

Related Posts

Inmazeb (REGN-EB3) antibodies target the Ebola virus glycoprotein

LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection

January 30, 2023
Robert Canter

Tumor microbiome linked to immunotherapy success in sarcoma patients

January 30, 2023

Rice lab uncovers dynamics behind protein crucial in breast cancer

January 30, 2023

KAIST presents a fundamental technology to remove metastatic traits from lung cancer cells​

January 30, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    64 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

An illuminated water droplet creates an ‘optical atom’

Connections between peripheral artery disease, negative social determinants of health like poverty may lead to earlier diagnosis, intervention in at-risk Blacks

Monitoring an ‘anti-greenhouse’ gas: Dimethyl sulfide in Arctic air

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In